Clinical trials
Phase 4 Atrial Fibrillation trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
71 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 7 |
| 2016 | 8 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 71 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Deutsches Herzzentrum Muenchen | 4 |
| Centre of Postgraduate Medical Education | 3 |
| National Institute of Cardiology, Warsaw, Poland | 3 |
| Medtronic BRC | 2 |
| Neil Sulke | 2 |
| The First Affiliated Hospital with Nanjing Medical University | 2 |
| University of Sao Paulo General Hospital | 2 |
| Wuhan University | 2 |
| AZ Sint-Jan AV | 1 |
| Aarhus University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 71 |
| Coronary Artery Disease | 6 |
| Heart Failure | 6 |
| Stroke | 6 |
| Arrhythmias, Cardiac | 5 |
| Diabetes Mellitus | 3 |
| Hypertension | 3 |
| Hemorrhage | 2 |
| Sick Sinus Syndrome | 2 |
| Acute Coronary Syndrome | 1 |
Trials
Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.